OOIR: Observatory of International Research

Papers

(The TQCC of Current Hypertension Reports is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Urinary Biomarkers Of Kidney Function As Predictors Of Cardiovascular Health: A Systematic Review	218
Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease	117
Role of Inflammatory Processes in the Brain-Body Relationship Underlying Hypertension	93
Blood Pressure-Lowering Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists	64
Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis	61
Role of Female Sex Hormones and Immune Response in Salt-Sensitive Hypertension Development: Evidence from Experimental Models	54
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular Disease	53
Hypertension, Obesity, and Target Organ Injury in Children: An Emerging Health Care Crisis	52
Sodium Intake and Risk of Hypertension: A Systematic Review and Dose–Response Meta-analysis of Observational Cohort Studies	47
Effect of Different Classes of Antihypertensive Drugs on Arterial Stiffness	47
Approach to Endocrine Hypertension: A Case-Based Discussion	40
Integrated Care Model of Adiposity-Related Chronic Diseases	40
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition	39
Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction	38
A Critical Role for the Paraventricular Nucleus of the Hypothalamus in the Regulation of the Volume Reflex in Normal and Various Cardiovascular Disease States	34
Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review	34
Remote Blood Pressure Monitoring in Pregnancies at Risk of Developing Preeclampsia	27
Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension	27
Secondary Hypertension in Children—Identifying and Investigating at Risk Children	27
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease	25
Firibastat: a Novel Treatment for Hypertension	25
HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension Control	25
Cardiovascular Dysfunction in Intrauterine Growth Restriction	25
Blood Pressure Assessment and Treatment in the Observation Unit	23
Sodium-Directed Crosstalk Between Immune Cells and Lymphatic Vessels	23

Sex Difference of Alcoholic Hypertension: Mechanism and Targeted Therapy	22
Sympathetic Nervous System in Heart Failure: Targets for Treatments	21
Detecting and Managing Childhood Onset Hypertension in Africa: A Call to Action	21
The Burden of Resistant Hypertension Across the World	21
Lipoprotein (a) and Hypertension	21
Effects of Puberty on Blood Pressure Trajectories — Underlying Processes	19
Clinical Significance of Nocturnal Hypertension and Nighttime Blood Pressure Dipping in Hypertension	19
A Systematic Review of the Role of Telemedicine in Blood Pressure Control: Focus on Patient Engagement	19
Is Vitamin D Supplementation an Effective Treatment for Hypertension?	19
Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia	18
Beneficial Effects of Exercise on Hypertension-Induced Cardiac Hypertrophy in Adolescents and Young Adults	18
Salt Taste and Salt Sensitive Hypertension in HIV	18
Use of Self-Measured Blood Pressure Monitoring to Improve Hypertension Equity	18
Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions	17
Sex Differences in the Prevalence, Outcomes and Management of Hypertension	17
Interpreting High-Sensitive Troponins in Patients with Hypertension	17
Standardizing Blood Pressure Measurements in Pediatric Hemodialysis: a Collaborative Journey	16
Resistant Hypertension: Disease Burden and Emerging Treatment Options	16
The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers	16
Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases	16
White Coat Hypertension & Cardiovascular Outcomes	15
Recent Advances in Association Between Vitamin D Levels and Cardiovascular Disorders	15
Sympathetic Responses to Antihypertensive Treatment Strategies	15